Clinical Trial Update: An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide . [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluates the pharmacokinetic interaction between the oral contraceptive Brevicon and the GLP-1 receptor agonist albiglutide. The study in ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)
• Brevicon (ethinyl estradiol and norethindrone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED